The increased follow-up of recommended imaging exams combined with the efficiency of its use also generated an additional $9,000 in revenue per month at one organization.
“No one wants to get surgery if they can avoid it. Now we have a powerful tool to help patients and their doctors predict who would benefit from surgery after initial chemotherapy and radiation."
The facility will provide much needed developmental and manufacturing support for pharmaceutical companies that produce and distribute medical isotopes.
Significant fluctuations in PET and CT reimbursement rates have made it especially challenging to keep up with this complex topic. We spoke to an expert to learn more.
It has long been believed that hormone therapy could have neuroprotective effects on the brain. However, new data suggests that this isn't the case for every woman.
By binding the substance to a radiotracer, experts were able to improve the accuracy of identifying these tumors by as much as 30% compared to the standard of care.